Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019;17(2):142-150.
doi: 10.2174/1570159X15666171109161140.

The Role of CXCR3 in Neurological Diseases

Ya-Qun Zhou  1   2 , Dai-Qiang Liu  1   2 , Shu-Ping Chen  1   2 , Jia Sun  1   2 , Xue-Rong Zhou  3 , Cui Xing  4 , Da-Wei Ye  3 , Yu-Ke Tian  1   2
Affiliations
Review

The Role of CXCR3 in Neurological Diseases

Ya-Qun Zhou et al. Curr Neuropharmacol. 2019.

Abstract

Background: Neurological diseases have become an obvious challenge due to insufficient therapeutic intervention. Therefore, novel drugs for various neurological disorders are in desperate need. Recently, compelling evidence has demonstrated that chemokine receptor CXCR3, which is a G protein-coupled receptor in the CXC chemokine receptor family, may play a pivotal role in the development of neurological diseases. The aim of this review is to provide evidence for the potential of CXCR3 as a therapeutic target for neurological diseases.

Methods: English journal articles that focused on the invovlement of CXCR3 in neurological diseases were searched via PubMed up to May 2017. Moreover, reference lists from identified articles were included for overviews.

Results: The expression level of CXCR3 in T cells was significantly elevated in several neurological diseases, including multiple sclerosis (MS), glioma, Alzheimer's disease (AD), chronic pain, human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and bipolar disorder. CXCR3 antagonists showed therapeutic effects in these neurological diseases.

Conclusion: These studies provided hard evidence that CXCR3 plays a vital role in the pathogenesis of MS, glioma, AD, chronic pain, HAM/TSP and bipolar disorder. CXCR3 is a crucial molecule in neuroinflammatory and neurodegenerative diseases. It regulates the activation of infiltrating cells and resident immune cells. However, the exact functions of CXCR3 in neurological diseases are inconclusive. Thus, it is important to understand the topic of chemokines and the scope of their activity in neurological diseases.

Keywords: Alzheimer’s disease; CXCL10; CXCR3; chronic pain; multiple sclerosis; neurological disease..

PubMed Disclaimer

References

    1. Oliver D.J., Borasio G.D., Caraceni A., de Visser M., Grisold W., Lorenzl S., Veronese S., Voltz R. A consensus review on the development of palliative care for patients with chronic and progressive neurological disease. Eur. J. Neurol. 2015;23(1):30–38. [PMID: 26423203]. - PubMed
    1. Xu Y., Tian X.B., An K., Yang H., Tian Y.K. Lumbar transplantation of immortalized enkephalin-expressing astrocytes attenuates chronic neuropathic pain. Eur. J. Pain. 2008;12(4):525–533. [http://dx.doi.org/10.1016/j.ejpain.2007.08.005]. [PMID: 17904399]. - PubMed
    1. Ramesh G., MacLean A.G., Philipp M.T. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm. 2013;2013:480739. [http://dx.doi.org/10.1155/2013/480739]. [PMID: 23997430]. - PMC - PubMed
    1. Han D., Wu C., Xiong Q., Zhou L., Tian Y. Anti-inflammatory mechanism of bone marrow mesenchymal stem cell transplantation in rat model of spinal cord injury. Cell Biochem. Biophys. 2015;71(3):1341–1347. [http://dx.doi.org/10.1007/s12013-014-0354-1]. [PMID: 25388837]. - PubMed
    1. Griffith J.W., Sokol C.L., Luster A.D. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu. Rev. Immunol. 2014;32:659–702. [http://dx.doi.org/10. 1146/annurev-immunol-032713-120145]. [PMID: 24655300]. - PubMed